1. Home
  2. CYTK vs NXT Comparison

CYTK vs NXT Comparison

Compare CYTK & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.83

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Logo Nextracker Inc.

NXT

Nextracker Inc.

SELL

Current Price

$87.90

Market Cap

12.6B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
CYTK
NXT
Founded
1997
2013
Country
United States
United States
Employees
N/A
1993
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.6B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
CYTK
NXT
Price
$60.83
$87.90
Analyst Decision
Buy
Strong Buy
Analyst Count
22
29
Target Price
$109.90
★ $137.61
AVG Volume (30 Days)
★ 1.8M
1.8M
Earning Date
11-04-2026
10-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 10.66
EPS
N/A
★ 1.07
Revenue
$13,368,000.00
★ $3,559,390,000.00
Revenue This Year
$70.12
$21.79
Revenue Next Year
$183.63
$19.44
P/E Ratio
★ N/A
$82.11
Revenue Growth
N/A
★ 20.28
52 Week Low
$54.30
$76.72
52 Week High
$88.31
$163.13

Technical Indicators

Market Signals
Indicator
CYTK
NXT
Relative Strength Index (RSI) 24.31 57.41
Support Level $59.05 $86.69
Resistance Level $67.04 $103.63
Average True Range (ATR) 2.06 3.47
MACD -0.37 1.09
Stochastic Oscillator 3.95 81.99

Price Performance

Historical Comparison
CYTK
NXT

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About NXT Nextracker Inc.

Nextpower (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextpower's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextpower has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Share on Social Networks: